357 related articles for article (PubMed ID: 10926939)
1. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke.
Christou I; Alexandrov AV; Burgin WS; Wojner AW; Felberg RA; Malkoff M; Grotta JC
Stroke; 2000 Aug; 31(8):1812-6. PubMed ID: 10926939
[TBL] [Abstract][Full Text] [Related]
2. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring.
Alexandrov AV; Demchuk AM; Felberg RA; Christou I; Barber PA; Burgin WS; Malkoff M; Wojner AW; Grotta JC
Stroke; 2000 Mar; 31(3):610-4. PubMed ID: 10700493
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator.
Demchuk AM; Burgin WS; Christou I; Felberg RA; Barber PA; Hill MD; Alexandrov AV
Stroke; 2001 Jan; 32(1):89-93. PubMed ID: 11136920
[TBL] [Abstract][Full Text] [Related]
4. CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke.
Alexandrov AV; Wojner AW; Grotta JC;
J Neuroimaging; 2004 Apr; 14(2):108-12. PubMed ID: 15095554
[TBL] [Abstract][Full Text] [Related]
5. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
[TBL] [Abstract][Full Text] [Related]
6. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
[TBL] [Abstract][Full Text] [Related]
7. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.
Alexandrov AV; Grotta JC
Neurology; 2002 Sep; 59(6):862-7. PubMed ID: 12297567
[TBL] [Abstract][Full Text] [Related]
8. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement.
Alexandrov AV; Burgin WS; Demchuk AM; El-Mitwalli A; Grotta JC
Circulation; 2001 Jun; 103(24):2897-902. PubMed ID: 11413077
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial.
Alexandrov AV; Demchuk AM; Burgin WS; Robinson DJ; Grotta JC;
J Neuroimaging; 2004 Apr; 14(2):113-7. PubMed ID: 15095555
[TBL] [Abstract][Full Text] [Related]
10. Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke.
Felberg RA; Okon NJ; El-Mitwalli A; Burgin WS; Grotta JC; Alexandrov AV
Stroke; 2002 May; 33(5):1301-7. PubMed ID: 11988607
[TBL] [Abstract][Full Text] [Related]
11. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke.
Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hill MD; Alexandrov AV;
Stroke; 2007 Mar; 38(3):961-6. PubMed ID: 17255548
[TBL] [Abstract][Full Text] [Related]
12. Ischemic stunning of the brain: early recanalization without immediate clinical improvement in acute ischemic stroke.
Alexandrov AV; Hall CE; Labiche LA; Wojner AW; Grotta JC
Stroke; 2004 Feb; 35(2):449-52. PubMed ID: 14726543
[TBL] [Abstract][Full Text] [Related]
13. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study.
Saqqur M; Molina CA; Salam A; Siddiqui M; Ribo M; Uchino K; Calleja S; Garami Z; Khan K; Akhtar N; O'Rourke F; Shuaib A; Demchuk AM; Alexandrov AV;
Stroke; 2007 Jan; 38(1):69-74. PubMed ID: 17138949
[TBL] [Abstract][Full Text] [Related]
14. Residual flow at the site of intracranial occlusion on transcranial Doppler predicts response to intravenous thrombolysis: a multi-center study.
Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Shuaib A; Alexandrov AV;
Cerebrovasc Dis; 2009; 27(1):5-12. PubMed ID: 19018132
[TBL] [Abstract][Full Text] [Related]
15. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
[TBL] [Abstract][Full Text] [Related]
16. Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion.
Christou I; Felberg RA; Demchuk AM; Burgin WS; Malkoff M; Grotta JC; Alexandrov AV
J Neuroimaging; 2002 Apr; 12(2):119-23. PubMed ID: 11977905
[TBL] [Abstract][Full Text] [Related]
17. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.
Molina CA; Ribo M; Rubiera M; Montaner J; Santamarina E; Delgado-Mederos R; Arenillas JF; Huertas R; Purroy F; Delgado P; Alvarez-Sabín J
Stroke; 2006 Feb; 37(2):425-9. PubMed ID: 16373632
[TBL] [Abstract][Full Text] [Related]
18. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques.
Ribo M; Alvarez-Sabín J; Montaner J; Romero F; Delgado P; Rubiera M; Delgado-Mederos R; Molina CA
Stroke; 2006 Apr; 37(4):1000-4. PubMed ID: 16514102
[TBL] [Abstract][Full Text] [Related]
19. Arterial status after intravenous TPA therapy for ischaemic stroke. A need for further interventions.
Christou I; Burgin WS; Alexandrov AV; Grotta JC
Int Angiol; 2001 Sep; 20(3):208-13. PubMed ID: 11573054
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol.
Ribo M; Molina CA; Rovira A; Quintana M; Delgado P; Montaner J; Grivé E; Arenillas JF; Alvarez-Sabín J
Stroke; 2005 Mar; 36(3):602-6. PubMed ID: 15692107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
